ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-tuberculosis Medicine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-3I7518
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti tuberculosis Medicine Market Insights Forecast to 2028
BUY CHAPTERS

Global Anti-tuberculosis Medicine Market Research Report 2025

Code: QYRE-Auto-3I7518
Report
July 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lupin Ltd
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer Inc
Novartis
Abbott
Astrazeneca plc
Bayer
Eli Lilly
GlaxoSmithKline PLC
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical

Anti-tuberculosis Medicine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-tuberculosis Medicine Market

Anti-tuberculosis Medicine Market

The global market for Anti-tuberculosis Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-tuberculosis Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-tuberculosis Medicine.
The Anti-tuberculosis Medicine market size, estimations, and forecasts are provided in terms of sales volume (Kiliton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-tuberculosis Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-tuberculosis Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-tuberculosis Medicine Market Report

Report Metric Details
Report Name Anti-tuberculosis Medicine Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Government Agencies
  • Non-Profit Organizations
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck, Sanofi, Chongqing Huapont Pharm, Shuangding Pharm, Hongqi pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-tuberculosis Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-tuberculosis Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Anti-tuberculosis Medicine Market report?

Ans: The main players in the Anti-tuberculosis Medicine Market are Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca, Bayer, Eli Lilly, GlaxoSmithKline, Merck, Sanofi, Chongqing Huapont Pharm, Shuangding Pharm, Hongqi pharmaceutical

What are the Application segmentation covered in the Anti-tuberculosis Medicine Market report?

Ans: The Applications covered in the Anti-tuberculosis Medicine Market report are Hospitals and Clinics, Government Agencies, Non-Profit Organizations, Others

What are the Type segmentation covered in the Anti-tuberculosis Medicine Market report?

Ans: The Types covered in the Anti-tuberculosis Medicine Market report are Isoniazid, Rifampin, Ethambutol, Pyrazinamide, Otherr

Recommended Reports

Pharmaceutical Drugs

Diagnostics & Testing

Disease Treatment Markets

1 Anti-tuberculosis Medicine Market Overview
1.1 Product Definition
1.2 Anti-tuberculosis Medicine by Type
1.2.1 Global Anti-tuberculosis Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Isoniazid
1.2.3 Rifampin
1.2.4 Ethambutol
1.2.5 Pyrazinamide
1.2.6 Otherr
1.3 Anti-tuberculosis Medicine by Application
1.3.1 Global Anti-tuberculosis Medicine Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Clinics
1.3.3 Government Agencies
1.3.4 Non-Profit Organizations
1.3.5 Others
1.4 Global Anti-tuberculosis Medicine Market Size Estimates and Forecasts
1.4.1 Global Anti-tuberculosis Medicine Revenue 2020-2031
1.4.2 Global Anti-tuberculosis Medicine Sales 2020-2031
1.4.3 Global Anti-tuberculosis Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti-tuberculosis Medicine Market Competition by Manufacturers
2.1 Global Anti-tuberculosis Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti-tuberculosis Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti-tuberculosis Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti-tuberculosis Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-tuberculosis Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-tuberculosis Medicine, Product Type & Application
2.7 Global Key Manufacturers of Anti-tuberculosis Medicine, Date of Enter into This Industry
2.8 Global Anti-tuberculosis Medicine Market Competitive Situation and Trends
2.8.1 Global Anti-tuberculosis Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-tuberculosis Medicine Players Market Share by Revenue
2.8.3 Global Anti-tuberculosis Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-tuberculosis Medicine Market Scenario by Region
3.1 Global Anti-tuberculosis Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti-tuberculosis Medicine Sales by Region: 2020-2031
3.2.1 Global Anti-tuberculosis Medicine Sales by Region: 2020-2025
3.2.2 Global Anti-tuberculosis Medicine Sales by Region: 2026-2031
3.3 Global Anti-tuberculosis Medicine Revenue by Region: 2020-2031
3.3.1 Global Anti-tuberculosis Medicine Revenue by Region: 2020-2025
3.3.2 Global Anti-tuberculosis Medicine Revenue by Region: 2026-2031
3.4 North America Anti-tuberculosis Medicine Market Facts & Figures by Country
3.4.1 North America Anti-tuberculosis Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti-tuberculosis Medicine Sales by Country (2020-2031)
3.4.3 North America Anti-tuberculosis Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-tuberculosis Medicine Market Facts & Figures by Country
3.5.1 Europe Anti-tuberculosis Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti-tuberculosis Medicine Sales by Country (2020-2031)
3.5.3 Europe Anti-tuberculosis Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-tuberculosis Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-tuberculosis Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti-tuberculosis Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti-tuberculosis Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-tuberculosis Medicine Market Facts & Figures by Country
3.7.1 Latin America Anti-tuberculosis Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti-tuberculosis Medicine Sales by Country (2020-2031)
3.7.3 Latin America Anti-tuberculosis Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-tuberculosis Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-tuberculosis Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti-tuberculosis Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-tuberculosis Medicine Sales by Type (2020-2031)
4.1.1 Global Anti-tuberculosis Medicine Sales by Type (2020-2025)
4.1.2 Global Anti-tuberculosis Medicine Sales by Type (2026-2031)
4.1.3 Global Anti-tuberculosis Medicine Sales Market Share by Type (2020-2031)
4.2 Global Anti-tuberculosis Medicine Revenue by Type (2020-2031)
4.2.1 Global Anti-tuberculosis Medicine Revenue by Type (2020-2025)
4.2.2 Global Anti-tuberculosis Medicine Revenue by Type (2026-2031)
4.2.3 Global Anti-tuberculosis Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Anti-tuberculosis Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti-tuberculosis Medicine Sales by Application (2020-2031)
5.1.1 Global Anti-tuberculosis Medicine Sales by Application (2020-2025)
5.1.2 Global Anti-tuberculosis Medicine Sales by Application (2026-2031)
5.1.3 Global Anti-tuberculosis Medicine Sales Market Share by Application (2020-2031)
5.2 Global Anti-tuberculosis Medicine Revenue by Application (2020-2031)
5.2.1 Global Anti-tuberculosis Medicine Revenue by Application (2020-2025)
5.2.2 Global Anti-tuberculosis Medicine Revenue by Application (2026-2031)
5.2.3 Global Anti-tuberculosis Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Anti-tuberculosis Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Lupin
6.1.1 Lupin Company Information
6.1.2 Lupin Description and Business Overview
6.1.3 Lupin Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Lupin Anti-tuberculosis Medicine Product Portfolio
6.1.5 Lupin Recent Developments/Updates
6.2 Macleods Pharmaceuticals
6.2.1 Macleods Pharmaceuticals Company Information
6.2.2 Macleods Pharmaceuticals Description and Business Overview
6.2.3 Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Macleods Pharmaceuticals Anti-tuberculosis Medicine Product Portfolio
6.2.5 Macleods Pharmaceuticals Recent Developments/Updates
6.3 Otsuka Pharmaceutical
6.3.1 Otsuka Pharmaceutical Company Information
6.3.2 Otsuka Pharmaceutical Description and Business Overview
6.3.3 Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Otsuka Pharmaceutical Anti-tuberculosis Medicine Product Portfolio
6.3.5 Otsuka Pharmaceutical Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Company Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Johnson & Johnson Anti-tuberculosis Medicine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Anti-tuberculosis Medicine Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Anti-tuberculosis Medicine Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Abbott
6.7.1 Abbott Company Information
6.7.2 Abbott Description and Business Overview
6.7.3 Abbott Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Abbott Anti-tuberculosis Medicine Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca Anti-tuberculosis Medicine Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Company Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Bayer Anti-tuberculosis Medicine Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 Eli Lilly
6.10.1 Eli Lilly Company Information
6.10.2 Eli Lilly Description and Business Overview
6.10.3 Eli Lilly Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eli Lilly Anti-tuberculosis Medicine Product Portfolio
6.10.5 Eli Lilly Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Company Information
6.11.2 GlaxoSmithKline Description and Business Overview
6.11.3 GlaxoSmithKline Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 GlaxoSmithKline Anti-tuberculosis Medicine Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Merck
6.12.1 Merck Company Information
6.12.2 Merck Description and Business Overview
6.12.3 Merck Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Merck Anti-tuberculosis Medicine Product Portfolio
6.12.5 Merck Recent Developments/Updates
6.13 Sanofi
6.13.1 Sanofi Company Information
6.13.2 Sanofi Description and Business Overview
6.13.3 Sanofi Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sanofi Anti-tuberculosis Medicine Product Portfolio
6.13.5 Sanofi Recent Developments/Updates
6.14 Chongqing Huapont Pharm
6.14.1 Chongqing Huapont Pharm Company Information
6.14.2 Chongqing Huapont Pharm Description and Business Overview
6.14.3 Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Chongqing Huapont Pharm Anti-tuberculosis Medicine Product Portfolio
6.14.5 Chongqing Huapont Pharm Recent Developments/Updates
6.15 Shuangding Pharm
6.15.1 Shuangding Pharm Company Information
6.15.2 Shuangding Pharm Description and Business Overview
6.15.3 Shuangding Pharm Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shuangding Pharm Anti-tuberculosis Medicine Product Portfolio
6.15.5 Shuangding Pharm Recent Developments/Updates
6.16 Hongqi pharmaceutical
6.16.1 Hongqi pharmaceutical Company Information
6.16.2 Hongqi pharmaceutical Description and Business Overview
6.16.3 Hongqi pharmaceutical Anti-tuberculosis Medicine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hongqi pharmaceutical Anti-tuberculosis Medicine Product Portfolio
6.16.5 Hongqi pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-tuberculosis Medicine Industry Chain Analysis
7.2 Anti-tuberculosis Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-tuberculosis Medicine Production Mode & Process Analysis
7.4 Anti-tuberculosis Medicine Sales and Marketing
7.4.1 Anti-tuberculosis Medicine Sales Channels
7.4.2 Anti-tuberculosis Medicine Distributors
7.5 Anti-tuberculosis Medicine Customer Analysis
8 Anti-tuberculosis Medicine Market Dynamics
8.1 Anti-tuberculosis Medicine Industry Trends
8.2 Anti-tuberculosis Medicine Market Drivers
8.3 Anti-tuberculosis Medicine Market Challenges
8.4 Anti-tuberculosis Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Lupin Ltd
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer Inc
Novartis
Abbott
Astrazeneca plc
Bayer
Eli Lilly
GlaxoSmithKline PLC
Merck
Sanofi
Chongqing Huapont Pharm
Shuangding Pharm
Hongqi pharmaceutical
List of Tables
 Table 1. Global Anti-tuberculosis Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti-tuberculosis Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti-tuberculosis Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti-tuberculosis Medicine Sales (Kiliton) of Key Manufacturers (2020-2025)
 Table 5. Global Anti-tuberculosis Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti-tuberculosis Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti-tuberculosis Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti-tuberculosis Medicine Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti-tuberculosis Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-tuberculosis Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-tuberculosis Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-tuberculosis Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-tuberculosis Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tuberculosis Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-tuberculosis Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti-tuberculosis Medicine Sales by Region (2020-2025) & (Kiliton)
 Table 18. Global Anti-tuberculosis Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Anti-tuberculosis Medicine Sales by Region (2026-2031) & (Kiliton)
 Table 20. Global Anti-tuberculosis Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Anti-tuberculosis Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti-tuberculosis Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti-tuberculosis Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti-tuberculosis Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti-tuberculosis Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti-tuberculosis Medicine Sales by Country (2020-2025) & (Kiliton)
 Table 27. North America Anti-tuberculosis Medicine Sales by Country (2026-2031) & (Kiliton)
 Table 28. North America Anti-tuberculosis Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti-tuberculosis Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti-tuberculosis Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti-tuberculosis Medicine Sales by Country (2020-2025) & (Kiliton)
 Table 32. Europe Anti-tuberculosis Medicine Sales by Country (2026-2031) & (Kiliton)
 Table 33. Europe Anti-tuberculosis Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti-tuberculosis Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti-tuberculosis Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti-tuberculosis Medicine Sales by Region (2020-2025) & (Kiliton)
 Table 37. Asia Pacific Anti-tuberculosis Medicine Sales by Region (2026-2031) & (Kiliton)
 Table 38. Asia Pacific Anti-tuberculosis Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti-tuberculosis Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-tuberculosis Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti-tuberculosis Medicine Sales by Country (2020-2025) & (Kiliton)
 Table 42. Latin America Anti-tuberculosis Medicine Sales by Country (2026-2031) & (Kiliton)
 Table 43. Latin America Anti-tuberculosis Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti-tuberculosis Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti-tuberculosis Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2020-2025) & (Kiliton)
 Table 47. Middle East and Africa Anti-tuberculosis Medicine Sales by Country (2026-2031) & (Kiliton)
 Table 48. Middle East and Africa Anti-tuberculosis Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti-tuberculosis Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti-tuberculosis Medicine Sales (Kiliton) by Type (2020-2025)
 Table 51. Global Anti-tuberculosis Medicine Sales (Kiliton) by Type (2026-2031)
 Table 52. Global Anti-tuberculosis Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Anti-tuberculosis Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Anti-tuberculosis Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti-tuberculosis Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti-tuberculosis Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti-tuberculosis Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti-tuberculosis Medicine Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Anti-tuberculosis Medicine Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Anti-tuberculosis Medicine Sales (Kiliton) by Application (2020-2025)
 Table 61. Global Anti-tuberculosis Medicine Sales (Kiliton) by Application (2026-2031)
 Table 62. Global Anti-tuberculosis Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Anti-tuberculosis Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Anti-tuberculosis Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti-tuberculosis Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti-tuberculosis Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti-tuberculosis Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti-tuberculosis Medicine Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Anti-tuberculosis Medicine Price (US$/Ton) by Application (2026-2031)
 Table 70. Lupin Company Information
 Table 71. Lupin Description and Business Overview
 Table 72. Lupin Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Lupin Anti-tuberculosis Medicine Product
 Table 74. Lupin Recent Developments/Updates
 Table 75. Macleods Pharmaceuticals Company Information
 Table 76. Macleods Pharmaceuticals Description and Business Overview
 Table 77. Macleods Pharmaceuticals Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Macleods Pharmaceuticals Anti-tuberculosis Medicine Product
 Table 79. Macleods Pharmaceuticals Recent Developments/Updates
 Table 80. Otsuka Pharmaceutical Company Information
 Table 81. Otsuka Pharmaceutical Description and Business Overview
 Table 82. Otsuka Pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Otsuka Pharmaceutical Anti-tuberculosis Medicine Product
 Table 84. Otsuka Pharmaceutical Recent Developments/Updates
 Table 85. Johnson & Johnson Company Information
 Table 86. Johnson & Johnson Description and Business Overview
 Table 87. Johnson & Johnson Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Johnson & Johnson Anti-tuberculosis Medicine Product
 Table 89. Johnson & Johnson Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Pfizer Anti-tuberculosis Medicine Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Novartis Anti-tuberculosis Medicine Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. Abbott Company Information
 Table 101. Abbott Description and Business Overview
 Table 102. Abbott Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. Abbott Anti-tuberculosis Medicine Product
 Table 104. Abbott Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. AstraZeneca Anti-tuberculosis Medicine Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Bayer Company Information
 Table 111. Bayer Description and Business Overview
 Table 112. Bayer Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Bayer Anti-tuberculosis Medicine Product
 Table 114. Bayer Recent Developments/Updates
 Table 115. Eli Lilly Company Information
 Table 116. Eli Lilly Description and Business Overview
 Table 117. Eli Lilly Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Eli Lilly Anti-tuberculosis Medicine Product
 Table 119. Eli Lilly Recent Developments/Updates
 Table 120. GlaxoSmithKline Company Information
 Table 121. GlaxoSmithKline Description and Business Overview
 Table 122. GlaxoSmithKline Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. GlaxoSmithKline Anti-tuberculosis Medicine Product
 Table 124. GlaxoSmithKline Recent Developments/Updates
 Table 125. Merck Company Information
 Table 126. Merck Description and Business Overview
 Table 127. Merck Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Merck Anti-tuberculosis Medicine Product
 Table 129. Merck Recent Developments/Updates
 Table 130. Sanofi Company Information
 Table 131. Sanofi Description and Business Overview
 Table 132. Sanofi Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Sanofi Anti-tuberculosis Medicine Product
 Table 134. Sanofi Recent Developments/Updates
 Table 135. Chongqing Huapont Pharm Company Information
 Table 136. Chongqing Huapont Pharm Description and Business Overview
 Table 137. Chongqing Huapont Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. Chongqing Huapont Pharm Anti-tuberculosis Medicine Product
 Table 139. Chongqing Huapont Pharm Recent Developments/Updates
 Table 140. Shuangding Pharm Company Information
 Table 141. Shuangding Pharm Description and Business Overview
 Table 142. Shuangding Pharm Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 143. Shuangding Pharm Anti-tuberculosis Medicine Product
 Table 144. Shuangding Pharm Recent Developments/Updates
 Table 145. Hongqi pharmaceutical Company Information
 Table 146. Hongqi pharmaceutical Description and Business Overview
 Table 147. Hongqi pharmaceutical Anti-tuberculosis Medicine Sales (Kiliton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 148. Hongqi pharmaceutical Anti-tuberculosis Medicine Product
 Table 149. Hongqi pharmaceutical Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Anti-tuberculosis Medicine Distributors List
 Table 153. Anti-tuberculosis Medicine Customers List
 Table 154. Anti-tuberculosis Medicine Market Trends
 Table 155. Anti-tuberculosis Medicine Market Drivers
 Table 156. Anti-tuberculosis Medicine Market Challenges
 Table 157. Anti-tuberculosis Medicine Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-tuberculosis Medicine
 Figure 2. Global Anti-tuberculosis Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-tuberculosis Medicine Market Share by Type: 2024 & 2031
 Figure 4. Isoniazid Product Picture
 Figure 5. Rifampin Product Picture
 Figure 6. Ethambutol Product Picture
 Figure 7. Pyrazinamide Product Picture
 Figure 8. Otherr Product Picture
 Figure 9. Global Anti-tuberculosis Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Anti-tuberculosis Medicine Market Share by Application: 2024 & 2031
 Figure 11. Hospitals and Clinics
 Figure 12. Government Agencies
 Figure 13. Non-Profit Organizations
 Figure 14. Others
 Figure 15. Global Anti-tuberculosis Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Anti-tuberculosis Medicine Market Size (2020-2031) & (US$ Million)
 Figure 17. Global Anti-tuberculosis Medicine Sales (2020-2031) & (Kiliton)
 Figure 18. Global Anti-tuberculosis Medicine Average Price (US$/Ton) & (2020-2031)
 Figure 19. Anti-tuberculosis Medicine Report Years Considered
 Figure 20. Anti-tuberculosis Medicine Sales Share by Manufacturers in 2024
 Figure 21. Global Anti-tuberculosis Medicine Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest Anti-tuberculosis Medicine Players: Market Share by Revenue in Anti-tuberculosis Medicine in 2024
 Figure 23. Anti-tuberculosis Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global Anti-tuberculosis Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America Anti-tuberculosis Medicine Sales Market Share by Country (2020-2031)
 Figure 26. North America Anti-tuberculosis Medicine Revenue Market Share by Country (2020-2031)
 Figure 27. United States Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe Anti-tuberculosis Medicine Sales Market Share by Country (2020-2031)
 Figure 30. Europe Anti-tuberculosis Medicine Revenue Market Share by Country (2020-2031)
 Figure 31. Germany Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific Anti-tuberculosis Medicine Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific Anti-tuberculosis Medicine Revenue Market Share by Region (2020-2031)
 Figure 38. China Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. China Taiwan Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Anti-tuberculosis Medicine Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Anti-tuberculosis Medicine Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Anti-tuberculosis Medicine Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Anti-tuberculosis Medicine Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Anti-tuberculosis Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Anti-tuberculosis Medicine by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Anti-tuberculosis Medicine by Type (2020-2031)
 Figure 59. Global Anti-tuberculosis Medicine Price (US$/Ton) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Anti-tuberculosis Medicine by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Anti-tuberculosis Medicine by Application (2020-2031)
 Figure 62. Global Anti-tuberculosis Medicine Price (US$/Ton) by Application (2020-2031)
 Figure 63. Anti-tuberculosis Medicine Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Active Tuberculosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mycobacterium Tuberculosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Mycobacterium Tuberculosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Antituberculosis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Tuberculosis Vaccine Market Research Report 2025
Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti infectious Disease Drugs Market Research Report 2025
Global Feed Anticoccidials Market Insights Forecast to 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Infectives Market Research Report 2025
HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic BCG Vaccines Market Insights Forecast to 2030
Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Depression Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ant Killer Market Research Report 2024
Antimania Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions